The regulation of body fat equilibrium in mammals depends on a balance between diet and energy expenditure. Energy expenditure occurs as a result of a combination of resting metabolic rate, physical exercise and non-shivering thermogenesis. It has become increasingly evident that even small calorific inequalities can lead to an increase in fat storage and obesity. There is also an intimate association between increasing body weight and Type II (non-insulin-dependent) diabetes even in populations in which obesity is not a common problem. The recent addition of two new uncoupling proteins (UCP), UCP2 and UCP3 to the mitochondrial carrier protein family of genes provides new opportunities to study thermogenesis in humans [1±3]. Activated uncoupling proteins promote proton transport and consequently decrease the proton electrochemical potential gradient across the inner mitochondrial membrane. This uncouples oxidative phosphorylation of ADP to ATP, leading to generation of heat [4] . A close relation between obesity in mice Diabetologia (1999) 
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Abstract
Aims/hypothesis. Linkage between markers close to the uncoupling protein 2 and 3 genes (11q13) and resting metabolic rate and a pre-diabetic phenotype have been found. The syntenic region in mouse has been found to be linked to quantitative traits associated with obesity and diabetes. UCP2 and UCP3 could therefore have an important role in body weight regulation and susceptibility to diabetes. We investigated a recently identified variant of the UCP2 gene in exon 8 as a marker for glucose and weight homeostasis. Methods. Length variation of the UCP2 exon 8 variant was studied by the polymerase chain reaction and agarose gel electrophoresis. Sequence variants of the UCP3 gene were sought by semi-automated DNA sequencing. Results. In 453 South Indian subjects, we found an association in women between the UCP2 exon variant and body mass index (p = 0.018). These findings were replicated in a separate group of South Indian subjects (n = 143, p < 0.001) irrespective of sex. Although no association was found between the UCP2 exon 8 variant and overt obesity in British subjects, the UCP2 genotype of obese women (n = 83) correlated with fasting serum leptin concentration (p = 0.006) in the presence of extreme obesity. These observations could not be explained by tight linkage disequilibrium with a coding region variant in the region of the UCP3 gene of biological significance. Lastly, no association was found between UCP2 and Type II (non-insulin-dependent) diabetes using either a family based design (85 families) or case control study (normal glucose tolerance n = 335, impaired glucose tolerance n = 42, Type II diabetes n = 76). Conclusion/interpretation. We have described a UCP2 gene exon 8 variant that may affect susceptibility to weight gain by influencing regulation of leptin.
[Diabetologia (1999) 42: 688±693] Keywords Uncoupling protein genes, obesity, leptin, polymorphism.
and uncoupling protein 1 (UCP1) gene expression in brown adipose tissue (BAT) has been well established, although UCP1 knockout mice do not become obese [5] . The lack of substantial BAT in adult humans suggests that UCP1 has a limited role in thermogenesis in man. Associations between polymorphism of the UCP1 gene and various aspects of obesity have been reported, although these have not been consistent [6±7]. UCP2 and UCP3 (long transcript) both have six predicted transmembrane domains, as do UCP1 and other members of the mitochondrial carrier family of ion transporters of the inner mitochondrial membrane [1, 2, 8] . UCP2 has a wide tissue expression including white adipose tissue (WAT) whilst UCP3 is mainly expressed in skeletal muscle [2, 3] . Two recent studies have found linkage between markers in the vicinity of the uncoupling protein 2 and 3 genes (11q13), firstly with a resting metabolic rate in a French Canadian population [9] , and secondly a suggestive linkage with a prediabetic phenotype, (2 h OGTT insulin concentrations) in Pima Indians [10] . Furthermore, the syntenic region in mouse has been found to be linked to quantitative traits associated with obesity and diabetes [11, 12] . These findings suggest that UCP2 and UCP3 possibly have an important role in body weight regulation and the susceptibility to Type II diabetes in humans.
The primary purpose of our experiments was to study a recently identified UCP2 exon 8 variant [13] as a determinant of body mass index (BMI) and Type II diabetes in a group of South Indian subjects. This ethnic group was chosen for several reasons. Firstly, obesity is not as common in South Indians compared with European or North American Caucasians [14] . The effect of genetic variants might therefore be more pronounced in an ethnic group as yet not fully exposed to environmental factors that promote obesity compared with one in which the majority of the recent rise in the prevalence of obesity can be explained by modern lifestyle. Secondly, we had access to well characterised study groups including population and family based samples [14, 15] . On finding an association between the exon 8 UCP2 variant and BMI, we then proceeded to study a British Caucasoid group for an association with overt obesity. We further hypothesised that the presence of extreme obesity would unmask a defect of leptin secretion in those with the UCP2 variant, much like insulin resistance unmasks a beta-cell defect in those genetically susceptible to Type II diabetes.
Subjects and methods
South Indian cross-sectional survey. We recruited 453 South Indian subjects from Chennai as part of an urban survey of the prevalence of diabetes and associated risk factors. This number represents the majority of those subjects in whom whole blood was available and represents four of the eight colonies screened [14] . The mean age of the subjects was 45 ± 12 years, mean BMI 22.5 ± 4.2 kg/m 2 and 48.6 % were female; 73.7 % had normal glucose tolerance, 9.4 % impaired glucose tolerance and 16.9 % Type II diabetes.
South Indian families. Eighty-five South Indian families (255 members) were recruited as previously described [14] . For this experiment, families were studied consisting of the Type II diabetic proband and both parents. The mean age of onset of Type II diabetes in the probands was 33.8 ± 9.9 years, BMI 26.6 ± 4.7 kg/m 2 and 36 % were female. The treatment of the probands consisted of diet control (6 %), oral hypoglycaemics (80 %), and insulin (14 %). In the fathers, the mean age was 64.6 ± 6.8 years and mean BMI 25.2 ± 9.6 kg/m 2 and the figures in the mothers for age were 57.7 ± 6.5 years and mean BMI 25.7 ± 4.3 kg/m 2 .
British Caucasoids. One hundred and fifty-six obese subjects defined by a BMI of greater than 30 kg/m 2 were recruited from the Obesity Clinic at The Royal London Hospital (n = 116) or by local advertisement (n = 40). The mean BMI was 40.3 ± 6.4 kg/m 2 (range 30±67), mean age was 44.0 ± 11.5 and 86 % were female. We recruited 91 slim control subjects (males, BMI < 27 and females, BMI < 25 kg/m 2 ) from amongst the staff at The Royal London Hospital. The mean BMI was 21.6 ± 2.0 kg/m 2 (range 17.3±26.3), mean age 31.9 ± 9.5 years and 71 % were female. A dietary review confirmed that none of the obese subjects was following a very restrictive diet at the time of venesection.
Method. Genomic DNA was extracted from blood samples collected in EDTA using the Qiamp 96 system (Qiagen, Crawley, UK). DNA was amplified using primers flanking the insertion in exon 8 (5 ¢-forward CAGTGAGGGAAGTGGGAGG, 5 ¢-reverse GGGGCAGGACGAAGATTC) of the UCP2 gene and separated by 2 % agarose gel electrophoresis. Alleles were scored after ethidium bromide staining and recorded using an Alpha Imaging System (Alpha Innotech/Flowgen, Lichfield, UK). Homozygotes for the UCP2 exon 8 variant were verified by sequencing. The seven exons and part of the putative 5 ¢ regulatory region of the UCP3 gene were sequenced in 15 subjects representing all UCP2 exon 8 variants and both ethnic groups. PCR amplification of UCP3 exons were done as previously described [16] . Primers for the regulatory region were based on sequences deposited with GDB (AF032 871). Direct sequencing was by standard methods using an ABI 373 DNA Sequencer and TaqFS Dye terminator sequencing (Perkin-Elmer, Applied Biosystems, Warrington, UK).
Fasting serum leptins were taken in 83 obese women and determined by radioimmunoassay using a commercially available kit (Linco Research, St. Louis, Mo., USA). The kit uses a polyclonal antibody against highly purified human leptin and both the calibrators and 125 I-labelled tracer are prepared with recombinant human leptin. The intra-and the inter-assay coefficients of variation were 3.4 % and 3.6 % respectively at a leptin concentration of 25.6 mg/l. Statistical analysis. Contingency tables were analysed by Chi square and continuous variables by ANOVA (SPSS for Windows, version 7.5). In the families, transmission of alleles from the parents to the Type II diabetic proband was analysed by the extended transmission disequilibrium test (ETDT) [17] .
Results
We defined three UCP2 genotypes (II, ID and DD) according to length variation of exon 8, depending on the presence of an insertion or deletion. The exon 8 I homozygote was present only in 5 % of both South Indian and British Caucasoid cohorts; the DD genotype was the most frequent genotype. Therefore, thè I' allele was assumed to be the variant and the`D' allele to be the normal or`wild' allele. The UCP2 exon 8 variant was confirmed in our sample group by nucleotide sequencing of an`I' homozygote and was found to be a 45 base pair insertion in the 3 ¢ non-coding region, which is a duplication of the 5 ¢ preceding 45 base pairs. In the`D' homozygote the insertion was not present.
In 453 South Indian subjects recruited from a cross-sectional survey, we found an association between UCP2 exon 8 genotype and BMI in women (Table 1 ; p = 0.018) but not in men (p = 0.33). In the women, the exon 8 I homozygotic subjects had higher BMIs than either the heterozygotic or D homozygotic ones. When the data was re-analysed using a covariate of age, the main effect was between BMI and genotype UCP2 (p = 0.015; overall model p = 0.036). To replicate the positive BMI findings, a further 143 South Indian subjects (consisting of parents of Type II diabetic probands) were studied and a similar association was found (Table 1 ; p < 0.0001); this was true even when fathers and mothers were analysed separately. In British Caucasoid subjects no association was found between UCP2 exon 8 genotype and overt obesity (p = 0.07) or for BMI within the obese subjects (p = 0.28). In obese women in whom fasting leptins were available (n = 83), an association was seen between fasting serum leptin concentration and UCP2 exon 8 genotype (Table 2 ; p = 0.006). The lowest leptin values were associated with the heterozygotic subjects. Although the mean fasting leptin concentration in the four homozygotic subjects for the variant was higher than in the heterozygotic ones, the 95 % confidence limits spanned the confidence limits for both the heterozygotic and the homozygotic wild subjects. This association was also found if fasting serum leptin was corrected for BMI (p = 0.004).
In South Indians, we found no association between Type II diabetes and the UCP2 exon 8 variant in 85 families using the extended transmission disequilibrium test (p = 0.45) or in the cross-sectional survey (3´3 Chi square, p = 0.83; normal glucose tolerance n = 335, impaired glucose tolerance n = 42 and Type II diabetes n = 76).
Sequencing of the coding regions of UCP3 in 15 subjects, five for each UCP2 exon 8 genotype from both South Indian and British Caucasian groups, showed no new mutations. Two previously described neutral polymorphisms in exon 3 (codon 99T®C) and on exon 5 (codon 200C®T) [15] were found in our sample group. At codon 99 of the UCP3 gene 14 of 15 subjects sequenced had the T allele; the one remaining subject had the variant C allele and was homozygotic for the D allele at exon 8 of the UCP2 gene. At codon 200 of the UCP3 gene, the most common allele in the 15 subjects (South Indian and British Caucasoid) was the T allele present in all five I homozygotes, four of five heterozygotes and three of five D homozygotes for the exon 8 UCP2 gene polymorphic site. In the putative regulatory region (encompassing exon 1 and 400 base pairs upstream) we identified a novel variant consisting of a C to T transversion located six bases upstream of the TATAA box. The T allele was present in three of six of each UCP2 exon 8 D homozygotes and ID heterozygotes whereas all UCP2 exon 8 homozygotes were UCP3 C homozygotes. Hence both T and C alleles are associated with the UCP2 exon 8 D allele.
Discussion
Two groups have studied the UCP2 exon 8 variant [13, 18] . In Pima Indians, an association was found between the UCP2 exon 8 variant and both resting metabolic rate and BMI (although in the latter this was restricted to subjects older than 45 years). In French Caucasians, no association was found between the UCP2 variant and overt obesity (serum leptin was not reported) although in their data set no I homozygotes were found for the UCP2 variant. Several other groups have screened the UCP2 gene for variants but none have found the exon 8 insertion [19±22] . The only variant detected in these studies was an alanine for valine substitution at codon 55 (A55V, exon 4). This causes a conservative amino acid change of no functional significance when assessed as activity of the protein in a yeast expression vector (unpublished data). Within a juvenile obese group of Danish subjects, heterozygous carriers of the A55V variant had a lower BMI than the alanine homozygotic subjects (p = 0.04), although no overall association between obesity and the exon 4 variant was found. This and the data on the Pima Indians would therefore support our own observations and indicate that whilst UCP2 gene associations may not determine extreme obesity, they possibly influence weight homeostasis. This would suggest that the genes determining the range of BMI are not necessarily the same as those determining overt obesity. The data in obese British Caucasoid women indicate that the exon 8 variant allele is associated with a lower serum leptin concentration than would be expected by the BMI in the presence of extreme obesity. This suggests a changed interaction between BMI, leptin and UCP2 as a cause of obesity in a small proportion of patients. Leptin receptors have been found on a variety of tissues in addition to the central nervous system, including pancreatic islet cells, haemopoietic cells and adipocytes [23] . Indeed, in humans and rodents, it has been observed that leptin modulates UCP2 expression in adipocytes and islets independently of dietary intake [24] . A recent study has shown a positive correlation between UCP2 mRNA levels in adipose tissue and BMI; furthermore, calorie restriction in six lean and five obese subjects increased both UCP2 and UCP3 mRNA expression [25] . The intriguing relation between UCP2 genotype and serum leptin concentration that we have found is strongly supported by the recent findings of Surwit et al. who have identified a quantitative trait locus for leptin in the same chromosomal region as UCP2 and UCP3 in a mouse model of diet induced obesity and diabetes (personal communication). We would therefore speculate that UCP2 gene expression in white adipose tissue could regulate leptin concentrations. Genetically determined low leptin concentrations, however, are insufficient to lead to overt obesity by themselves but are possibly contributors to weight gain.
The exon 8 variant located in the 3 ¢ untranslated region of the gene might have an effect on UCP2 mRNA stability. This in turn could affect protein expression and determine body weight by influencing energy expenditure and thermogenesis. Any reduction in UCP2 mRNA stability could compromise a subject's ability to remove excess calories through thermogenesis, especially in a person with a propensity to obesity from other genetic or environmental influences. This hypothesis is supported by recent studies that found reduced UCP2 mRNA levels in the visceral fat of obese but not lean subjects [26] . Furthermore, a separate group has also reported decreased UCP2 (but not UCP3) mRNA expression in skeletal muscles of obese subjects [27] . Alternatively, the UCP2 variant could be in linkage disequilibrium with another variant within UCP2 or UCP3 so far not detected. The 3 ¢ extremity of UCP3 is located within less than 100 kb upstream of the transcriptional start site of UCP2 [8] . Although UCP2 expression is induced by diet, not all the tissues that express UCP2 have a major role in thermogenesis and therefore its role in regulating energy expenditure is still not clear [1] . UCP3 in humans is mainly expressed in skeletal muscle [3] and this tissue is responsible for the bulk of thermogenesis. UCP3 therefore makes an attractive candidate gene for both obesity and Type II diabetes. Our UCP3 sequencing data make it unlikely that the UCP2 exon 8 variant is in tight linkage disequilibrium with any biologically significant mutations in the UCP3 coding region which would lead to amino acid substitutions. The only variants found were the same as those recently reported in Danish subjects, consisting of two silent amino acid changes in exon 3 and 5 [16] . We cannot exclude, however, that variants of UCP3 not tightly linked to the UCP2 exon 8 insertion variant will be found in some obese subjects as our study was not set up to address this question. Indeed, we did observe a novel UCP3 regulatory region variant. Further studies are required to determine whether this variant is of functional significance and whether an association exists between it and either diabetes or obesity.
The negative result we have found in Type II diabetes in the South Indians is in accord with three other recently reported studies, using different methodologies and markers. One of these studies was unable to link chromosomal markers close to UCP2 to Type II diabetes [28] , whilst another found no association between Type II diabetes and the UCP2 A55V variant [19] . Within the Type II diabetic families, the former study did not find evidence of linkage between UCP2 and either BMI or waist-to-hip ratio although the lod scores were inconclusive at 0.89 and 0.99, respectively [28] . The A55V and an additional alanine to threonine at position 232 UCP2 variants have also been studied in Japanese subjects and no association with Type II diabetes were found [21] . Although a direct role of UCP2 in Type II diabetes seems unlikely, based on the genetic data, it is still conceivable that in some ethnic groups variants of UCP3 possibly contribute to the pathogenesis of Type II diabetes. Indeed, mRNA levels of UCP3 have been found to be considerably reduced in skeletal muscle of Type II diabetic patients compared with control subjects [29] .
In conclusion, the UCP2 exon 8 variant is associated with increased BMI but not with Type II diabetes in a South Indian study group. Although no association was seen between UCP2 genotype and overt obesity in the British Caucasoid subjects, lower serum leptin concentrations were associated with the UCP2 variant in the presence of extreme obesity. This is the first data suggesting that the UCP2 gene or a closely linked locus might influence susceptibility to weight gain by affecting regulation of serum leptin.
